1. Introduction {#sec1}
===============

Every year, more than 10 million pilgrims from over 180 countries arrive in the Kingdom of Saudi Arabia for a pilgrimage to the holy places of Islam [@bib1]. Around 2--3 million Muslims will perform the Hajj at fixed dates over a 6-day period, while the remaining pilgrims will participate in the Umrah, a shorter pilgrimage that can be done at anytime, although most pilgrims perform this activity during the month of Ramadan. The number of pilgrims undertaking the Hajj has increased by a factor 5 from 1920 to 2012 [@bib1].

The crowded conditions within a confined area and the close contact with others, particularly during the circumambulation of the Kaaba (Tawaf) inside the Grand Mosque in Makkah, lead to increased risk of pilgrims acquiring and spreading infectious diseases [@bib2]. Respiratory tract infections are the most common infections transmitted between pilgrims, and the majority of pilgrims will develop one form of respiratory tract infection or another during their few weeks in Makkah and Madinah [@bib3], [@bib4]. Cough attack rates over 90% have been recorded among pilgrims from various nationalities [@bib5], [@bib6], [@bib7]. Among ill pilgrims consulting at Mina primary health structures, 60% present with respiratory tract infection symptoms [@bib8]. Respiratory tract infection is the leading cause of hospitalization in Saudi Hospitals during the Hajj, with a level as high as 57% in one study [@bib9]. Pneumonia accounts for 20--40% of hospitalization in tertiary care structures [@bib9], [@bib10] and for 55--67% of admissions to intensive care units [@bib11], [@bib12].

Several transmissible viral respiratory infections have been reported to cause upper respiratory tract infections in Hajj pilgrims [@bib3], [@bib13]. Published studies over recent years and including large panels of viruses tested by multiplex PCR provided new insights in the epidemiology of viral respiratory tract infections at the Hajj.

The objective of this paper is to summarize available data about the prevalence of virus carriage potentially responsible for respiratory tract infections among Hajj pilgrims as well as data about carriage acquisition and circulation of respiratory viruses among pilgrims before and after participating in the Hajj.

2. Methods {#sec2}
==========

2.1. Search strategy and selection criteria {#sec2.1}
-------------------------------------------

The systematic review was conducted according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines (<http://www.prisma-statement.org>). The following databases were searched, attempting to identify all relevant studies published from January 1980 to April 2015: Scopus (<http://www.scopus.com/>), PubMed (<http://www.ncbi.nlm.nih.gov/pubmed>) and Google Scholar (<http://scholar.google.fr/>). The latest search was conducted on May 1, 2015. The topic search terms used for searching the databases were as follows:\#1: "hadj" OR "hajj" OR "pilgrimage";\#2: "respiratory";\#3: "viral" OR "virus" OR "viruses" OR "pathogens" OR "infection" OR "infections";\#4: \#1 AND \#2 AND \#3.

The Saudi Epidemiological Bulletin (<http://seb.drupalgardens.com/>) issues were systematically reviewed for relevant papers.

Only articles published in English were included based on common language charred by the authors.

For inclusion the article needed to fulfill the following criteria [@bib1]: It needed to be related to the Hajj pilgrimage [@bib2], report on screening in asymptomatic or symptomatic participants [@bib3], present virological data and [@bib4] report on virus carriage prevalence. We excluded case reports. The reference lists of reviews were screened to identify studies possibly missed by the search.

Two researchers (P.G. and S.B.) independently performed the screening of the abstracts. Any discordant result was discussed in consensus meetings. After screening the abstracts, the full text of the articles was assessed for eligibility by the same two researchers and selected or rejected for inclusion in the systematic review.

2.2. Data collection process {#sec2.2}
----------------------------

The following data (if available) were extracted from each article: year, study design, study population, type of sample, microbiological methods, pathogens investigated and their prevalence, influenza vaccination rates and its effect on influenza virus carriage prevalence. We made a distinction between surveys conducted among symptomatic patients only, most of whom were included when consulting for respiratory symptoms at medical structures or were included in other settings on the basis of suffering respiratory symptoms at the time of sampling and, broader surveys conducted among cohorts of pilgrims independently of their clinical status (i.e. symptomatic and asymptomatic individuals). In this latter group sampling in pilgrims presenting respiratory symptoms was not necessarily done at the time of symptoms.

2.3. Data synthesis and analysis {#sec2.3}
--------------------------------

As a result of the design of the studies (cross-sectional studies and cohort studies) and the heterogeneity in patient populations and diagnosis methods, a formal meta-analysis was not possible. Therefore, the study results were summarized to describe the main outcomes of interest (i.e. the prevalence of respiratory viruses before and/or after participation to the Hajj). If possible, percentages not presented in the articles were calculated from the available data.

3. Results {#sec3}
==========

3.1. Study selection {#sec3.1}
--------------------

A total of 95 articles were found from the search, eleven additional references were found through manual search. After screening of titles and summaries, 32 articles were selected for full-text assessment [@bib6], [@bib7], [@bib14], [@bib15], [@bib16], [@bib17], [@bib18], [@bib19], [@bib20], [@bib21], [@bib22], [@bib23], [@bib24], [@bib25], [@bib26], [@bib27], [@bib28], [@bib29], [@bib30], [@bib31], [@bib32], [@bib33], [@bib34], [@bib35], [@bib36], [@bib37], [@bib38], [@bib39], [@bib40], [@bib41], [@bib42], [@bib43]. All 32 articles were included in the qualitative synthesis of the systematic review ([Fig. 1](#fig1){ref-type="fig"} ).Figure 1Flow diagram of searching strategy.

3.2. Studies conducted among selected population of symptomatic pilgrims suffering respiratory symptoms {#sec3.2}
-------------------------------------------------------------------------------------------------------

See [Table 1](#tbl1){ref-type="table"} .Table 1Prevalence of respiratory viruses in studies conducted among pilgrims suffering from respiratory symptoms.YearStudy designStudy populationType of sampleMicrobiological techniquesPathogens investigatedPrevalence (%)Influenza vaccination (%)Reference1991--1992Cross-sectional study (Saudi Arabia)Pilgrims suffering URTI[a](#tbl1fna){ref-type="table-fn"} and LRTI[b](#tbl1fnb){ref-type="table-fn"} and seeking care in four hospitals/medical centers (n = 761)Throat swabs, sputumCell culture/cytopathic effect and staining using virus-specific monoclonal antibodiesInfluenza A4.5[@bib14]Influenza B2.0Influenza overall6.5Parainfluenza 12.0Parainfluenza 21.7Parainfluenza 32.2Parainfluenza overall5.9Adenovirus4.7Respiratory syncytial virus2.4Mixed viral infectionsNDNo virus80.61994Cross-sectional study (Saudi Arabia)Pilgrims suffering pneumonia[c](#tbl1fnc){ref-type="table-fn"} and seeking care in two hospitals (n = 64)Serum, sputum broncho-alveolar lavage and naso-pharyngeal aspirateDirect immunofluorescence stainingInfluenza A3.1[@bib15]Influenza B1.6Influenza overall4.7Parainfluenza 10Parainfluenza 21.6Parainfluenza 30Adenovirus0Respiratory syncytial virus0Mixed viral infections0No virus89.1%2000Cross sectional study (Saudi Arabia)Pilgrims suffering ILI[d](#tbl1fnd){ref-type="table-fn"} and presenting at outpatient clinics (n = 305)SerumELISAInfluenza A5.94.3[@bib16]Influenza B11.5Influenza overall14.8Mixed viral infectionsNDNo virus82.0%2003Cross-sectional study (Saudi Arabia)Pilgrims suffering URTI[e](#tbl1fne){ref-type="table-fn"} and seeking care in three hospitals (n = 500)Throat swabsCell culture/cytopathic effect and staining using virus-specific monoclonal antibodiesInfluenza A0.64.4%[@bib17]Influenza B5.4Influenza overall6.0Parainfluenza 1,2,30.8Adenovirus0Respiratory syncytial virus1.4Enterovirus0Mixed viral infectionsNDNo virus89.2%2004Cross-sectional study (Saudi Arabia)Pilgrims suffering ILI[f](#tbl1fnf){ref-type="table-fn"} and seeking care in hospitals/medical centers (n = 360)Throat swabNot describedInfluenza overall12.82.2%[@bib18](including 70.9% influenza B Sichuan, 1.8% influenza B Hong Kong, 14.6% influenza A untyped, 7.3% influenza A-H1N1, 5.5% influenza A-H3N2 calculated from a mixed sample of 46 positive pilgrims and 9 positives non-pilgrims)Mixed viral infectionsNDNo virus84.7%2004--2005Cross-sectional study (Saudi Arabia)Iranian pilgrims suffering respiratory symptoms[g](#tbl1fng){ref-type="table-fn"} and presenting at to medical centers (n = 105)Gargled pharyngeal secretions, and serumCell culture/cytopathic effect and staining using virus-specific monoclonal antibodies - ELISAInfluenza A (pharynx)1.9[@bib19]Influenza B (pharynx)11.4Influenza overall13.3Parainfluenza (pharynx)0Adenovirus (pharynx)36.2Respiratory syncytial virus (pharynx)1.9Influenza A-H1N1 (serology)6.9Influenza A-H3N2 (serology)6.1Influenza B-Hong Kong (serology)8.5Influenza B-Sichuan (serology)12.3Influenza overall (serology)21.5Mixed viral infectionsNDNo virus (pharynx)48.6%No virus (serology)58.1%2005Cross-sectional study (Saudi Arabia)Pilgrims[h](#tbl1fnh){ref-type="table-fn"} suffering respiratory symptoms[i](#tbl1fni){ref-type="table-fn"} attending the British Hajj Delegation clinic in Mecca, or at Mina encampment (n = 202)Nasal swabsRapid diagnostic test (QuickVue) - PCRInfluenza rapid test4.527.7[@bib20]Influenza A-H1N10.5Influenza A-H3N29.9Influenza B3.5Influenza overall13.9Respiratory syncytial virus4.5Mixed viral infectionsNDNo virus86.12005Cross-sectional study (Saudi Arabia)International pilgrims suffering respiratory symptoms[f](#tbl1fnf){ref-type="table-fn"} recruited at two hospitals and at two airports (n = 483)Throat swabNot describedInfluenza overall9.729.9[@bib21](including 17.0% influenza B Sichuan, 6.4% influenza B Hong Kong, 29.8% influenza A untyped, 34.0% influenza A-H1N1, 12.8% influenza A-H3N2)Mixed viral infectionsNDNo virus90.32005--2006Cross-sectional study (Saudi Arabia and UK)UK pilgrims suffering respiratory symptoms[j](#tbl1fnj){ref-type="table-fn"} during their stay in Saudi Arabia or upon returning to the UK (n = 555)Nasal swabsRapid diagnostic test (QuickVue) - PCRInfluenza (Rapid test)3.2[@bib22]Influenza-A (PCR)8.2Influenza B (PCR)2.3Influenza overall (PCR)10.5Mixed viral infectionsNDNo virus90.1%2006Cross-sectional study (Saudi Arabia)British pilgrims suffering respiratory symptoms[k](#tbl1fnk){ref-type="table-fn"} attending the British Hajj Delegation clinic in Mecca or at Mina encampment (n = 150) and Saudi pilgrims[k](#tbl1fnk){ref-type="table-fn"} attending the National Guard Health Affair clinic at Mina (n = 110)Nasal swabsRapid diagnostic test (QuickVue) - PCRInfluenza rapid test3.523.1[@bib23]Influenza A8.1Influenza B2.3Influenza overall10.4Parainfluenza 10Parainfluenza 20Parainfluenza 30.4Parainfluenza overall0.4Respiratory syncytial virus0.4Rhinovirus9.2Mixed viral infections0.8%No virus85.4%2006Cross-sectional airport study (Iran)Iranian Returning pilgrims suffering ARI[l](#tbl1fnl){ref-type="table-fn"} (n = 255)Nasal washCell culture/cytopathic effect and staining using virus-specific monoclonal antibodies - PCRInfluenza A5.185.5%[@bib24]Influenza B5.1Influenza overall10.2Parainfluenza 15.5Parainfluenza 21.6Parainfluenza 30.8Parainfluenza overall7.9Adenovirus5.5Respiratory syncytial virus1.6Rhinovirus5.9Enterovirus2.0Mixed viral infections0.4%No virus67.5%2009Cross sectional airport survey (Iran)Iranian returning pilgrims suffering respiratory symptoms[m](#tbl1fnm){ref-type="table-fn"} (n = 275)Throat swabsCell culture/cytopathic effect - PCRInfluenza A-H1N1 (culture)1.1100%[@bib25]Influenza A-H3N2 (culture)1.8Influenza B (culture)6.2Influenza overall (culture)9.1Influenza A-H1N1 (PCR)1.8Influenza A-H3N2 (PCR)2.9Influenza B (PCR)7.3Influenza overall (PCR)12.0Mixed viral infectionsNDNo virus (culture)90.9No virus (PCR)88.02010Cross-sectional airport study (Saudi Arabia)Arriving pilgrims[n](#tbl1fnn){ref-type="table-fn"} suffering from URTI[o](#tbl1fno){ref-type="table-fn"} (n = 713)Throat swabsNot describedInfluenza A-H1N13.126.9[@bib26]Influenza A-H3N21.7Influenza B-Hong Kong1.1Influenza B-Sichuan2.1Influenza overall8.0Respiratory syncytial virus3.1Mixed viral infectionsNDNo virus88.9%2011Cross-sectional study (Saudi Arabia)Australian pilgrims suffering from ILI[p](#tbl1fnp){ref-type="table-fn"}, at Mina encampment (n = 80)Nasal swabsPCRInfluenza A6.3[@bib27]Influenza B3.8Influenza overall10.1Parainfluenza 10Parainfluenza 20Parainfluenza 31.3Rhinovirus48.8Enterovirus2.5Mixed viral infections2.5No virus41.32013Cross-sectional study (Saudi Arabia)Pilgrims[q](#tbl1fnq){ref-type="table-fn"} suffering from ILI[r](#tbl1fnr){ref-type="table-fn"}, at Mina encampment (n = 112)Naso-pharyngeal or throat swabsPCRInfluenza A-H1N10.931.3%[@bib28]Influenza A-H3N23.6Influenza overall4.5Parainfluenza 10.9Parainfluenza 20Parainfluenza 31.8Parainfluenza overall2.7Rhinovirus26.8Adenovirus2.7Coronavirus OC43 and 229E2.7Mixed viral infections2.7No virus62.52013Cross sectional study (Saudi Arabie)Pilgrims[s](#tbl1fns){ref-type="table-fn"} admitted to 15 healthcare facilities with bilateral pneumonia (n = 38)SputumPCRInfluenza A15.8[@bib29]Influenza B0Parainfluenza 10Parainfluenza 20Parainfluenza 32.6Parainfluenza 40Parainfluenza overall2.6Adenovirus0Respiratory syncytial virus2.6MERS-Cov0CoV-229E7.9CoV-NL630CoV-HKU10CoV-OC435.3CoV overall13.2Enterovirus0Metapneumovirus0Rhinovirus39.5Bocavirus0Mixed viral infections15.8No virus56.72014National survey (Austria)Returning Austrian pilgrims seeking care[t](#tbl1fnt){ref-type="table-fn"} in hospitals/medical centers (n = 7)Serum, sputum, throat swab, or bronchoalveolar lavagePCRMERS-CoV00[@bib30]Influenza A-H1N10Influenza A-H3N228.6Influenza B42.9Influenza overall71.4Rhinovirus26.6Mixed viral infections0No virus0[^1][^2][^3][^4][^5][^6][^7][^8][^9][^10][^11][^12][^13][^14][^15][^16][^17][^18][^19][^20]

### 3.2.1. Study characteristics {#sec3.2.1}

A total of 17 studies were conducted from 1991 through 2014 among a total of 5075 pilgrims suffering from upper respiratory tract infections, influenza-like illness, lower tract respiratory infection, or pneumonia. Definition of syndromes differed according to authors. Sample size varied from 7 to 761 individuals. Design of survey included:-Ten cross-sectional surveys conducted at tertiary care hospitals and primary health care centers in Saudi Arabia [@bib14], [@bib15], [@bib16], [@bib17], [@bib18], [@bib19], [@bib20], [@bib21], [@bib23], [@bib30], two of which included additional pilgrims recruited at Mina encampment [@bib20], [@bib23] and one included additional pilgrims recruited at two airports [@bib21],-Three cross-sectional surveys conducted at Mina encampment (n = 2) or during the stay in Saudi Arabia and upon returning to the UK (n = 1) [@bib22], [@bib27], [@bib28].-Three airport cross-sectional surveys conducted at a Saudi airport among arriving pilgrims (n = 1) or at an Iranian airport among returning pilgrims (n = 2) [@bib24], [@bib25], [@bib26].-One national study conducted in hospitals and medical centers in Austria among returning pilgrims [@bib30].

Most studies were conducted among mixed populations of pilgrims with different nationalities although some countries were predominant in several studies [@bib14], [@bib15], [@bib16], [@bib17], [@bib18], [@bib21], [@bib26], [@bib28], [@bib29]. Some studies were conducted among specific populations including Iranian, British, Australian and Austrian pilgrims [@bib19], [@bib20], [@bib22], [@bib23], [@bib24], [@bib25], [@bib27], [@bib30].

Types of samples included were throat swabs, nasal swabs, naso-pharyngeal swabs, sputum, broncho-alveolar and naso-pharyngeal aspirates, gargled pharyngeal secretions and serum.

Early studies were based on cell culture/cytopathic effect and staining using virus-specific monoclonal antibodies or rapid tests for antigen detection (respiratory samples) and ELISA (serum samples) [@bib14], [@bib15], [@bib16], [@bib17], [@bib19], [@bib20], [@bib22], [@bib23], [@bib24], [@bib25], while most recent studies used PCR (respiratory samples), [@bib20], [@bib22], [@bib23], [@bib24], [@bib25], [@bib27], [@bib28], [@bib29], [@bib30].

### 3.2.2. Carriage of influenza virus {#sec3.2.2}

Prevalence of influenza viruses was investigated in all 16 studies. Two distinct methods of detection were used in some studies, showing a higher sensitivity of ELISA compared to cell culture and of PCR compared to antigen detection and cell culture. When considering the results from the most sensitive methods in each study, the prevalence of influenza viruses ranged 4.5--15.8% (with the exception of one study involving 7 patients only, where it was 71.4% [@bib30]) with prevalence of influenza A ranging 0.6--15.8% and prevalence of influenza B ranging 0--11.5% (with the exception of one study involving 7 patients only, where it was 28.6% for influenza A and 42.9% for influenza B [@bib30]).

Selected analysis of a subset of seven recent studies with similar design using PCR in nasal and or throat swabs from patients suffering ILI or other upper respiratory tract infection symptoms showed prevalence of influenza virus ranging 4.5--13.9%, prevalence of influenza A ranging 4.5--10.4% and prevalence of influenza B ranging 2.3--7.3% [@bib20], [@bib22], [@bib23], [@bib24], [@bib25], [@bib27], [@bib28]. A PCR study of sputum from patients suffering bilateral pneumonia showed 15.8% prevalence of influenza viruses (all influenza A) [@bib29]. In one additional small survey conducted among seven Austrian patients, two were infected with influenza A and three with influenza B [@bib30].

Vaccination rates against influenza were documented in 10 studies ranging from 0 to 100%. Effect of vaccination on influenza detection prevalence was investigated in 6 studies and no statistically significant effect was observed with the following results: 7.7% in vaccinated pilgrims vs. 14.1% in unvaccinated pilgrims (OR = 0.47, 95% CI = 1.01--3.33) [@bib16], 14.3% vs. 13.4% (no statistical test performed) [@bib20], 4.9% vs. 12.0% (p \> 0.05) [@bib21], 7.1% vs. 14.3% (p = 0.19) [@bib23], 9.2% vs. 16.5% (p = 0.19) [@bib24], 2.9% vs. 5.2% (p = 1.58) [@bib28].

### 3.2.3. Carriage of parainfluenza viruses {#sec3.2.3}

Parainfluenza prevalence was investigated in nine studies using various methods of detection, four of which used PCR [@bib14], [@bib15], [@bib17], [@bib19], [@bib23], [@bib24], [@bib27], [@bib28], [@bib29]. The prevalence of parainfluenza viruses ranged 0--7.9% with prevalence of parainfluenza 1 ranging 0--5.5%, that parainfluenza 2 ranging 0--1.7% and that of parainfluenza 3 ranging 0--2.6%. Parainfluenza 4 was investigated in one PCR-based study and was not detected.

### 3.2.4. Carriage of respiratory syncytial virus {#sec3.2.4}

Respiratory syncytial virus prevalence was investigated in nine studies [@bib14], [@bib15], [@bib17], [@bib19], [@bib20], [@bib23], [@bib24], [@bib26], [@bib29], four of which included PCR detection [@bib20], [@bib23], [@bib24], [@bib29]. The prevalence of respiratory syncitial virus detection ranged 0--4.5% overall and 0.4--4.5% in PCR-based studies.

### 3.2.5. Carriage of metapneumovirus {#sec3.2.5}

Metapneumovirus was investigated in one PCR-based study and was not detected [@bib29].

### 3.2.6. Carriage of rhinovirus {#sec3.2.6}

Rhinovirus prevalence was investigated in six studies [@bib23], [@bib24], [@bib27], [@bib28], [@bib29], [@bib30] all using PCR detection, in nasal and or throat swabs from patients suffering ILI or other upper respiratory tract infection symptoms in four studies, and in sputum from patients suffering bilateral pneumonia in one study. The prevalence of rhinovirus detection ranged 5.9--48.8%.

### 3.2.7. Carriage of adenovirus {#sec3.2.7}

Adenovirus prevalence was investigated in seven studies [@bib14], [@bib15], [@bib17], [@bib19], [@bib24], [@bib28], [@bib29], three of which included PCR detection [@bib24], [@bib28], [@bib29]. The prevalence of adenovirus detection ranged 0--36.2% overall and 0--5.5% in PCR-based studies.

### 3.2.8. Carriage of enterovirus {#sec3.2.8}

Enterovirus prevalence was investigated in four studies [@bib17], [@bib24], [@bib27], [@bib29], three of which included PCR detection [@bib24], [@bib27], [@bib29]. The prevalence of enterovirus detection ranged 0--2.5%.

### 3.2.9. Carriage of coronaviruses {#sec3.2.9}

Coronaviruses prevalence was investigated in two PCR-based studies [@bib28], [@bib29], with 2.7% and 13.2% prevalence. Only coronaviruses 229E and OC43 were detected.

### 3.2.10. Mixed viral infections and bacterial surinfections {#sec3.2.10}

Co-infection by more than 1 virus were documented in 8 studies [@bib15], [@bib16], [@bib23], [@bib24], [@bib26], [@bib27], [@bib28], [@bib29], [@bib30] and ranged 0--28.9%. Bacterial infections were documented in 5 studies [@bib14], [@bib15], [@bib19], [@bib26], [@bib29], however, surinfection of viral infections by bacteria wad documented in two studies only its prevalence was 0 [@bib15] and 44.7% [@bib29].

3.3. Studies conducted among pilgrims irrespective of the respiratory status {#sec3.3}
----------------------------------------------------------------------------

See [Table 2](#tbl2){ref-type="table"} .Table 2Prevalence of respiratory viruses in studies conducted among pilgrims irrespective of the respiratory status.YearStudy designStudy populationType of sampleMicrobiological techniquesPathogens investigatedPrevalence (%)Influenza vaccination (%)Reference2003Paired cohort surveyUK pilgrims (n = 115)Serum before and after travelELISAInfluenza A-H1N12.6[k](#tbl2fnk){ref-type="table-fn"}26.1[@bib31]Influenza A-H3N236.5[k](#tbl2fnk){ref-type="table-fn"}Influenza B4.3[k](#tbl2fnk){ref-type="table-fn"}Influenza overall38.3[k](#tbl2fnk){ref-type="table-fn"}Mixed viral infections5.2[k](#tbl2fnk){ref-type="table-fn"}No virus61.7[k](#tbl2fnk){ref-type="table-fn"}2007--2008Paired cohort surveyIranian pilgrims[a](#tbl2fna){ref-type="table-fn"} (n = 338)Serum before and after travelELISAInfluenza3.6[k](#tbl2fnk){ref-type="table-fn"}84.0[@bib32]Respiratory syncytial virus7.4[k](#tbl2fnk){ref-type="table-fn"}Adenovirus23.7[k](#tbl2fnk){ref-type="table-fn"}Mixed viral infectionsNDNo virus65.4[k](#tbl2fnk){ref-type="table-fn"}2009Cross sectional ship port and airport survey (Egypt)Egyptian returning pilgrims (126 at ship port and 425 at airport)Nasopharyngeal swabsPCRInfluenza A-H1N1pdm09098.1[@bib33]Influenza A-H1N11.0Influenza A-H3N20Mixed viral infections0No virus992009Cross sectional airport survey (Iran)Iranian returning pilgrims[b](#tbl2fnb){ref-type="table-fn"} (n = 305)Pharyngeal swabsPCRInfluenza A-H1N1pdm091.697.7[@bib34]Influenza A-other2.6Influenza overall4.2Mixed viral infections95.8No virus02009Cross sectional airport survey (unpaired cohorts) (Saudi Arabia)Arriving (n = 519) and departing (n = 2699) pilgrims[c](#tbl2fnc){ref-type="table-fn"}Nasopharyngeal and throat swabsPCRInfluenza A-H1N10.2-0.153.3 (seasonal flu) and 38.8 (pdm09-H1N1)[@bib35]Influenza A-H3N20.2-0.3Influenza B0-0.1Influenza overall0.4-0.5Parainfluenza 10-0Parainfluenza 20-0Parainfluenza 30-0.1Parainfluenza 40-0Parainfluenza overall0-0.1Adenovirus0-0Respiratory syncytial virus0-0.3CoV-229E0-0.2CoV-NL630.2-0.1CoV-HKU10-0.1CoV-OC430-0.6CoV overall0.2-1.0Metapneumovirus0-0.1Rhinovirus12.1--13.0Bocavirus0-0Mixed viral infections0-0.1No virus87.5--85.22009Cross sectional survey (Saudi Arabia)Health care workers serving pilgrims, before and after the Hajj (n = 120)Combined nasal and throat swabsPCRInfluenza A-H1N10-050.9 (seasonal flu), 21.7 (pdm09-H1N1[@bib36]Influenza A-H3N20-0Influenza B0-0Influenza overall0-0Parainfluenza 10-0Parainfluenza 20-0Parainfluenza 30-0Parainfluenza 40-0Parainfluenza overall0-0Adenovirus0-0Respiratory syncytial virus0-0CoV-229E0-0.8CoV-NL630-0CoV-HKU10-0CoV-OC430-0CoV overall0-0.8Metapneumovirus0-0Rhinovirus7.5--11.7Bocavirus0-0Mixed viral infections0-0No virus92.5--87.52010Cross-sectional airport study (Saudi Arabia)Arriving pilgrims[d](#tbl2fnd){ref-type="table-fn"} (n = 1600)Throat swabsPCRInfluenza A-H1N1 pdm096.993.4[@bib37]Influenza A-H1N1 non-pdm090.6Influenza overall7.5Mixed viral infections--No virus92.52012Paired cohort surveyFrench pilgrims before arrival, during Hajj and at departure[e](#tbl2fne){ref-type="table-fn"}\
(n = 165)Nasal swabsPCRInfluenza A-H1N10-0-0[n](#tbl2fnn){ref-type="table-fn"}45.6 (2011)\[ [@bib6], [@bib38]\]Influenza A-H3N20-8.6-0Influenza B0-0-1.3Influenza C0.6-1.4-0Influenza overall0.6-10.0-1.3Adenovirus0.6-1.4-1.9Respiratory syncytial virus0-1.4-0MERS-Cov0-0-0Enterovirus0.6-1.4-0.6Metapneumovirus0-1.4-0Rhinovirus3.0-27.1-8.4[l](#tbl2fnl){ref-type="table-fn"}Mixed viral infections0-4.3-1.2No virus95.7-61.4-89.0[l](#tbl2fnl){ref-type="table-fn"}2013Paired cohort surveyFrench pilgrims before arrival and at departure[f](#tbl2fnf){ref-type="table-fn"} (n = 129)Nasal and throat swabsPCRInfluenza A-H1N10-0.8[o](#tbl2fno){ref-type="table-fn"}44.2 (2012)\[ [@bib7], [@bib39], [@bib40]\]Influenza A-H3N20-6.2[l](#tbl2fnl){ref-type="table-fn"}Influenza B0-0.8Influenza C1.7--0Influenza overall1.7--7.8Parainfluenza overall3.3-0.8Adenovirus1.7-0.0Respiratory syncytial virus0-0.8MERS-Cov0-0CoV-229E0-12.4[l](#tbl2fnl){ref-type="table-fn"}CoV-NL630-0.8CoV-HKU10-3.9CoV-OC430-3.9CoV overall0-20.9Cytomegalovirus0-0Enterovirus0.8-2.3Metapneumovirus1.7-0.8Rhinovirus14.0--14.7Bocavirus1.7--0Parechovirus0-0Mixed viral infections3.1--5.4No virus78.5-61.2[l](#tbl2fnl){ref-type="table-fn"}2013Cross sectional airport survey (unpaired cohorts) (Saudi Arabia)Arriving pilgrims[g](#tbl2fng){ref-type="table-fn"} (n = 3210) and departing pilgrims[g](#tbl2fng){ref-type="table-fn"} (n = 2025)Nasopharyngeal samplesPCRMERS-CoV0-022.0[@bib41]Mixed viral infections--No virus100-1002013Cross-sectional airport study (Ghana)Returning Ghanaian pilgrims[h](#tbl2fnh){ref-type="table-fn"} (n = 839)Nasopharyngeal swabsPCRInfluenza A1.3[@bib42]Rhinovirus16.8Respiratory Syncitial virus5.1MERS-CoV0Mixed viral infections1.9No virus78.72013Paired cohort survey/Unpaired cohort surveyPilgrims[i](#tbl2fni){ref-type="table-fn"} at arrival and subsequently at Mina (n = 692)/Pilgrims at arrival[i](#tbl2fni){ref-type="table-fn"} (n = 514) Pilgrims at Mina[j](#tbl2fnj){ref-type="table-fn"} (n = 470)Nasal swabsPCRInfluenza A-H1N10.1--1.6/0.2-3.0[m](#tbl2fnm){ref-type="table-fn"},[l](#tbl2fnl){ref-type="table-fn"}21.9[@bib43]Influenza A-H3N20.6-2.0/1.2-1.7Influenza B0-0/0-0.2Influenza C0-0/0-0Influenza overall0.7-3.6/1.4--4.9Parainfluenza 10-0/0.4--0Parainfluenza 20-0.3/0.2-0.4Parainfluenza 30.3-0.1/0-0.2Parainfluenza 40-0.1/0.2--0Parainfluenza overall0-0.5/0.8-0.6Adenovirus0-0.6/0-0.4Respiratory syncytial virus0.6-0.7/0.6-0.2MERS-Cov0-0/0-0CoV-229E0.9-14.6[l](#tbl2fnl){ref-type="table-fn"}/1.0-10.2[l](#tbl2fnl){ref-type="table-fn"}CoV-NL630.3-2.0/0-0.2CoV-HKU10.4-1.3/0.2-1.5^l^CoV-OC430.1--1.6/0.4-1.9[l](#tbl2fnl){ref-type="table-fn"}CoV overall1.7--19.5/1.6--13.8Cytomegalovirus0-0/0-0Enterovirus0.6-0.4/0.8-1.1Metapneumovirus0-0.1/0.2-0.6Rhinovirus2.2-34.4[l](#tbl2fnl){ref-type="table-fn"}/3.1-30.9[l](#tbl2fnl){ref-type="table-fn"}Bocavirus0.1-0/0.2--0Parechovirus0-0/0-0Mixed viral infections10.4 overallNo virus93.9-50.4[l](#tbl2fnl){ref-type="table-fn"}/91.4-54.9[l](#tbl2fnl){ref-type="table-fn"}[^21][^22][^23][^24][^25][^26][^27][^28][^29][^30][^31][^32][^33][^34][^35]

### 3.3.1. Study characteristics {#sec3.3.1}

A total of 12 studies were conducted from 2003 through 2013 among a total of 12,791 pilgrims [@bib6], [@bib7], [@bib31], [@bib32], [@bib33], [@bib34], [@bib35], [@bib36], [@bib37], [@bib38], [@bib39], [@bib40], [@bib41], [@bib42], [@bib43]. Sample size varied from 115 to 3210 individuals. The prevalence of cough was documented in 6 studies and varied from 48.2% to 92.7%. Design of survey included:-Five paired cohort surveys with longitudinal follow-up of same pilgrims before and after the Hajj [@bib6], [@bib7], [@bib31], [@bib32], [@bib38], [@bib39], [@bib40], [@bib43].-Three cross-sectional surveys comparing unpaired cohorts of different pilgrims before and after the Hajj, investigated at the airport and/or at Mina encampment [@bib35], [@bib42], [@bib43].-One cross-sectional survey comparing unpaired cohorts of different health care workers before and after the Hajj, investigated in Saudi hospitals [@bib36].-One cross-sectional survey among arriving pilgrims conducted in Saudi Arabia [@bib37].-Three cross-sectional surveys among returning pilgrims conducted in Egypt, Iran and Ghana respectively [@bib33], [@bib34], [@bib42].

Studies were conducted among mixed population of pilgrims from different nationalities [@bib35], [@bib37], [@bib41], [@bib43] or among specific populations including Egyptian, Iranian, British, French and Ghanaian pilgrims [@bib6], [@bib7], [@bib31], [@bib32], [@bib33], [@bib34], [@bib37], [@bib38], [@bib39], [@bib40], [@bib42]. Type of samples included throat swabs, nasal swabs, naso-pharyngeal swabs, and serum. Two studies were based on ELISA seroconversion [@bib31], [@bib32], while other studies used PCR (respiratory samples) [@bib6], [@bib7], [@bib33], [@bib34], [@bib35], [@bib36], [@bib37], [@bib38], [@bib39], [@bib40], [@bib41], [@bib42], [@bib43].

### 3.3.2. Carriage of influenza virus {#sec3.3.2}

Prevalence of influenza viruses was investigated in 11 studies [@bib6], [@bib7], [@bib31], [@bib32], [@bib33], [@bib34], [@bib35], [@bib36], [@bib37], [@bib38], [@bib39], [@bib40], [@bib42], [@bib43]. A 38.3% seroconversion rate was observed in one UK survey following participation in the Hajj (mostly due to influenza H3N2) while a 3.6% seroconversion rate was observed in one Iranian survey [@bib34]. Differences in influenza vaccination coverage may have accounted for this discrepancy with 26.1% among UK pilgrims compared to 84.0% among Iranian pilgrims. The prevalence by PCR studies among arriving pilgrims ranged 0.6--7.5% and 0.5--7.8% after the Hajj, with most cases being influenza A. The prevalence of influenza after the Hajj was statistically higher than before the Hajj in two studies [@bib39], [@bib43]. Vaccination rates against influenza in these PCR-based studies ranged from 21.9 to 98.1%. Effect of vaccination on influenza detection prevalence was investigated in 5 studies and no statistically significant effect was observed with the following results: 30.0% in vaccinated pilgrims vs. 38.3% in unvaccinated pilgrims (OR = 0.61, p = 0.28) [@bib31], 2.7% vs. 0 (no statistical test performed) [@bib34], 7.4 vs. 8.5% (p \> 0.05) [@bib35], no significant differences were observed in two study where details were not provided [@bib38], [@bib43].

Acquisition rate calculated from the largest paired cohort survey was 1.4% for influenza A/H1N1 and 1.9% for influenza A/H3N2 with an overall low 21.9% vaccination rate [@bib43]. The dynamic of influenza carriage was well addressed in one paired cohort survey with 0.6% influenza carriage prevalence in arriving pilgrims (none symptomatic), 10.0% carriage during the Hajj among symptomatic pilgrims and 1.3% carriage after the Hajj (90.4% symptomatic during the Hajj prior sampling, 2.0% still symptomatic at sampling) [@bib38]. In the one study conducted among health care workers, all samples were negative for influenza.

### 3.3.3. Carriage of parainfluenza viruses {#sec3.3.3}

Parainfluenza prevalence was investigated in five studies using PCR [@bib6], [@bib7], [@bib35], [@bib36], [@bib38], [@bib39], [@bib40], [@bib43]. The prevalence of parainfluenza virus detection among pilgrims ranged 0--3.3% before the Hajj and 0.1--0.8% after the Hajj. Acquisition rate calculated from the largest paired cohort survey was 0.1% [@bib43]. In the one study conducted among health care workers, all samples were negative for parainfluenza [@bib36].

### 3.3.4. Carriage of respiratory syncytial virus {#sec3.3.4}

Respiratory syncytial virus prevalence was investigated in seven studies [@bib6], [@bib7], [@bib32], [@bib35], [@bib38], [@bib40], [@bib42], [@bib43] six of which including PCR detection [@bib5], [@bib6], [@bib35], [@bib36], [@bib38], [@bib39], [@bib40], [@bib42], [@bib43]. The prevalence of respiratory virus detection among pilgrims ranged 0--0.6% before the Hajj and 0--5.1% after the Hajj in PCR-based studies. Acquisition rate calculated from the largest paired cohort survey was 0.7% [@bib43]. In the one study conducted among health care worker, all samples were negative for respiratory syncytial virus [@bib36].

### 3.3.5. Carriage of metapneumovirus {#sec3.3.5}

Metapneumovirus was investigated in five PCR-based study, [@bib6], [@bib7], [@bib35], [@bib36], [@bib38], [@bib39], [@bib40], [@bib43]. The prevalence of respiratory virus detection among pilgrims ranged 0--1.7% before the Hajj and 0--0.8% after the Hajj. Acquisition rate calculated from the largest paired cohort survey was 0.1% [@bib43]. In the one study conducted among health care worker, all samples were negative for metapneumovirus [@bib36].

### 3.3.6. Carriage of rhinovirus {#sec3.3.6}

Rhinovirus prevalence was investigated in six PCR studies [@bib6], [@bib7], [@bib35], [@bib36], [@bib38], [@bib39], [@bib40], [@bib42], [@bib43]. The prevalence of rhinovirus detection among pilgrims ranged 2.2--14.0% before the Hajj and 8.4--34.4% after the Hajj. The prevalence of rhinovirus after the Hajj was statistically higher than before the Hajj in two studies [@bib38], [@bib43]. Acquisition rate calculated from the largest paired cohort survey was 34.1% [@bib43]. The dynamic of rhinovirus carriage was well addressed in one paired cohort survey with 3.0% rhinovirus carriage prevalence in arriving pilgrims (none symptomatic), 27.1% carriage during the Hajj among symptomatic pilgrims and 8.4% carriage after the Hajj (90.4% symptomatic during the Hajj prior sampling, 2.0% still symptomatic at sampling) [@bib38]. In the one study conducted among health care workers, 7.5% of individuals tested positive before the Hajj and 11.7% after the Hajj [@bib36].

### 3.3.7. Carriage of adenovirus {#sec3.3.7}

Adenovirus prevalence was investigated in six studies [@bib6], [@bib7], [@bib32], [@bib35], [@bib36], [@bib38], [@bib39], [@bib40], [@bib43], five of which included PCR detection [@bib6], [@bib7], [@bib35], [@bib36], [@bib38], [@bib39], [@bib40], [@bib43]. The prevalence of respiratory virus detection among pilgrims ranged 0--1.7% before the Hajj and 0--0.6% after the Hajj in PCR-based studies. Acquisition rate calculated from the largest paired cohort survey was 0.6% [@bib43]. In the one study conducted among health care worker, all samples resulted negative for adenovirus [@bib36].

### 3.3.8. Carriage of enterovirus {#sec3.3.8}

Enterovirus prevalence was investigated in three PCR studies [@bib6], [@bib7], [@bib38], [@bib39], [@bib40], [@bib43]. The prevalence of enterovirus detection among pilgrims ranged 0.6--0.8% before the Hajj and 0.4--2.3% after the Hajj. Acquisition rate calculated from the largest paired cohort survey was 0.4% [@bib43].

### 3.3.9. Carriage of coronaviruses {#sec3.3.9}

Coronaviruses prevalence was investigated in seven PCR studies [@bib6], [@bib7], [@bib35], [@bib36], [@bib38], [@bib39], [@bib40], [@bib41], [@bib42], [@bib43]. The prevalence of non-coronavirus detection among pilgrims ranged 0.2--1.7% before the Hajj and 1.0--20.9% after the Hajj, with most infections due to coronavirus 229-E. The prevalence of non MERS-coronaviruses after the hajj was statistically higher than before the Hajj in two studies [@bib39], [@bib43]. Acquisition rate calculated from the largest paired cohort survey was 4.9% [@bib43]. In the one study conducted among health care worker, 0% individuals tested positive before the Hajj and 0.8% after the Hajj [@bib36]. MERS coronavirus was never isolated.

### 3.3.10. Carriage of bocavirus {#sec3.3.10}

Bocavirus was investigated in four PCR studies and detected among arriving pilgrims only in a few cases [@bib7], [@bib35], [@bib36], [@bib38], [@bib39], [@bib40], [@bib43].

### 3.3.11. Carriage of cytomegalovirus and parechovirus {#sec3.3.11}

Cytomegalovirus and parechovirus were investigated in two PCR studies and never detected [@bib7], [@bib38], [@bib39], [@bib40], [@bib43].

4. Discussion {#sec4}
=============

The viruses primarily associated with upper respiratory tract infections commonly include rhinoviruses, enteroviruses, adenoviruses, parainfluenza viruses, influenza viruses, respiratory syncytial viruses and coronaviruses 229E and OC43. Non-respiratory viruses including measles virus, herpes simplex virus 1, varicella zoster virus and cytomegalovirus may occasionally be responsible for respiratory involvement. In recent years new human respiratory viruses have been reported including human metapneumovirus, bocavirus, new human coronaviruses including Severe Acute Respiratory Syndrome coronavirus, human coronavirus NL63, and HKU1 and Middle East Respiratory Syndrome coronavirus [@bib44] and parechovirus [@bib45]. New variants of viruses have also emerged including human adenovirus-14, variant swine-like influenza H3N2, avian influenza H7N9 and H10N8 [@bib46].

In this review we show that the viruses most commonly isolated from symptomatic patients during the Hajj are rhinovirus (5.9--48.8% prevalence), followed by influenza virus (4.5--13.9%) and coronaviruses (2.7--13.2%) with most infections due to coronavirus 229E; other viruses are less frequently isolated. We also show that these viruses have low carriage rates among arriving pilgrims while an increase is observed in the carriage rate following participation in the Hajj. This increase was statistically significant for several viruses in certain studies including influenza AH1N1 [@bib43], influenza AH3N2 [@bib39], rhinovirus [@bib38], [@bib43], coronavirus 229E [@bib39], [@bib43], coronavirus HKU1 and OC43 [@bib43]. These cosmopolitan viruses are probably easily transmitted between pilgrims given the crowded conditions at the Holy Mosque and other religious sites around Mecca. The Holy Mosque\'s total capacity is 2 million and the average crowd density is at least four people per square meter and can reach levels of 6--8 people per square meter as people get closer to the Kaaba [@bib47]. It is also likely that housing conditions at Mina encampment in tents of 50--100 pilgrims play a role in the transmission of respiratory viruses [@bib27]. Overall, these results show an acquisition of viruses following the Hajj with high carriage prevalence among departing pilgrims. This suggests that an international mass gathering such as the Hajj may contribute to the globalization of common respiratory pathogens. Of note, emerging pathogens like SARS coronavirus and MERS coronavirus were not isolated from Hajj pilgrims until now, although rare cases of MERS have been reported among Umrah pilgrims [@bib48]. Mixed viral infections were relatively rare; however it depends mostly on the number of viruses investigated. The proportion of mixed viral infections reached 10.4% in a study where 21 different viruses were tested [@bib43].

Since therapeutic options are limited in the context of respiratory viral infections [@bib49] prevention is of paramount importance. Influenza vaccination is recommended to Hajj pilgrims by the Saudi Arabian Ministry of Health [@bib50]. In this review, no significant effect of influenza vaccination was observed on the carriage of influenza virus in individual studies and the uptake of seasonal influenza vaccine was very variable. The apparent lake of efficacy of vaccination against influenza in the context of the Hajj may result of a mismatch of circulating strains with vaccine strains [@bib51]. The effectiveness of influenza vaccine was assessed in pooled metadata from six studies included in the present review [@bib16], [@bib20], [@bib21], [@bib23], [@bib30], [@bib36] by other authors [@bib51]; influenza was significantly effective against laboratory-confirmed influenza (risk ratio 0.56; 95% CI 0.41--0.75; p \< 0.001). However a definitive conclusion should be not drawn from this analysis [@bib51]. Non-pharmaceutical interventions, such as hand hygiene, wearing a face mask, cough etiquette, social distancing, and contact avoidance can be effective in reducing the spread of respiratory viruses from person to person [@bib52] and are therefore recommended to Hajj pilgrims by national public health agencies [@bib50]. However, evidence of their effectiveness at the Hajj are limited and inconclusive and prospective cohort studies are required to confirm whether or not such non-pharmaceutical interventions are relevant for interrupting or reducing the spread of respiratory viruses during the annual Hajj pilgrimage [@bib53]. A cluster-randomized controlled trial is being conducted to provide valuable evidence on the efficacy of facemasks in preventing viral respiratory tract infections during the Hajj [@bib54].

Our review was limited to papers written in English which may have been a source of bias. There was an in important heterogeneity in studies in regards of study populations, clinical criteria for respiratory infections and diagnostic methods applied. The design of surveys conducted so far among pilgrims does not allow us to ascertain the role of viruses in the pathogenesis of respiratory symptoms and their potential role in the severity of the symptoms. The frequency of secondary bacterial infection could not be evaluated from the available studies since most surveys only addressed virus carriage and the number of viruses investigated was limited in many studies. The role of co-infection with viruses and bacteria warrants further investigation using ideally a paired cohort-survey design, allowing assessment of acquisition rate of a large panel of pathogens with sequential sampling and careful recording of clinical data associated with the highly common "Hajj cough" [@bib55].
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[^1]: Based on history and physical examination.

[^2]: Evidence of pulmonary consolidation on physical examination and radiograph.

[^3]: Acute episode associated with respiratory symptoms and radiological evidence of airspace disease of less than 4 weeks\' duration.

[^4]: Fever and at least two of the following: headaches, myalgia, cough, sore throat or coryza.

[^5]: Sore throat or fever ≥38.3 °C, and cough, headache, runny nose, sneezing, or myalgia.

[^6]: Fever of at least 38 °C, started within 72 h of presentation; along with history of cough and/or sore throat.

[^7]: Common cold defined by sore throat, rhinitis, fever, ILI defined by fever \>38.5 °C, myalgia, rhinitis and cough, sinubronchitis defined by headaches, purulent postnasal discharge or purulent sputum, cough and fever and pneumonia defined on radiographic findings.

[^8]: Mainly Indian pilgrims.

[^9]: Cough, sore throat, rhinorrhea and fever.

[^10]: Cough, sore throat, rhinorrhea and fever within one week of the onset.

[^11]: Cough, sore throat, rhinorrhea and fever.

[^12]: Two of the following conditions: fever, cough, sore throat, congestion, and sinus pain within the past 3 weeks during the Hajj.

[^13]: Cough, sore throat and fever.

[^14]: Mainly from Indonesia, Turkey and Pakistan.

[^15]: Fever and/or headaches and/or myalgia and at least of the following symptoms: runny nose, sneezing, sore throat, cough with or without sputum, difficulty of breathing.

[^16]: Subjective (or proven) fever plus one respiratory symptom (e.g. dry or productive cough, runny nose, sore throat, shortness of breath) for 3 days or less.

[^17]: Mainly from Saudi Arabia.

[^18]: Subjective (or proven) fever and at least one respiratory symptom such as cough, sore throat and rhinorrhea.

[^19]: Mainly from Asia.

[^20]: Fever and/or respiratory symptoms.

[^21]: Prevalence of cough = 84.3%, hoarseness = 64.6%, sore throat = 62.0%, rhinorrea = 54.2%, wheezing = 53.3%, headache = 44.1%, myalgia = 38.4%, fever = 36.4%, dyspnea = 22.2%.

[^22]: Prevalence of cough = 48.2%, sore throat = 46.2%, rhinorrhea = 60.7%, fever and cough = 10.5%.

[^23]: Mainly from Middle-East.

[^24]: Mainly from Indonesia, India, Algeria and Ivory Coast (prevalence of cough = 92.7% and sore-throat = 3.8%, smokers = 87.7%).

[^25]: Prevalence of cough = 83.4%, sore throat = 79.7%, rhinorrhea = 68.5%, dyspnea = 19.6%, ILI (fever and cough and sore-throat) = 41.0%.

[^26]: Prevalence of cough = 86.8%, sore throat = 82.9%, rhinorrhea = 72.1%, dyspnea = 21.7%, ILI (fever and cough and sore-throat) = 47.3%.

[^27]: Mainly from Asia and Africa.

[^28]: Prevalence of cough = 70.6%, sore throat = 40.9%, fever = 18.4%, runny-nose or sneezing = 18.1% and breathing difficulty = 14.8%.

[^29]: From Albania, Bangladesh, Egypt, Ethiopia, India, Indonesia, Malaysia, Pakistan, Somalia, Tanzania, prevalence of ILI = 61.9% at Mina.

[^30]: From Albania, Bangladesh, Egypt, Ethiopia, France, India, Indonesia, Malaysia, Nigeria, Pakistan, Somalia, Tanzania, prevalence of ILI = 61.9% at Mina.

[^31]: Seroconversion rate.

[^32]: Difference statistically significant (p \< 0.005, chi-scared test).

[^33]: Paired cohort at arrival-paired cohort at Mina/unpaired cohort at arrival-unpaired cohort at Mina.

[^34]: Before arrival-during Hajj-at departure.

[^35]: Before arrival-at departure (nasal swab)/before arrival-at departure (throat swab).
